Scott Grossman

Scott Grossman

UNVERIFIED PROFILE

Are you Scott Grossman?   Register this Author

Register author
Scott Grossman

Scott Grossman

Publications by authors named "Scott Grossman"

Are you Scott Grossman?   Register this Author

29Publications

941Reads

18Profile Views

Quantitation of Mycotoxins in Four Food Matrices Comparing Stable Isotope Dilution Assay (SIDA) with Matrix-Matched Calibration Methods by LC-MS/MS.

J AOAC Int 2019 Nov 2;102(6):1673-1680. Epub 2019 Apr 2.

Restek Corp., 110 Benner Circle, Bellefonte, PA 16823.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5740/jaoacint.19-0028DOI Listing
November 2019

Xpert MTB/RIF Ultra for Detection of Mycobacterium tuberculosis in Cerebrospinal Fluid.

J Clin Microbiol 2019 06 24;57(6). Epub 2019 May 24.

Department of Medical Microbiology, Makerere University, Kampala, Uganda.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JCM.00249-19DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535608PMC
June 2019

Clinical Reasoning: A 55-year-old obese woman with headache and rhinorrhea.

Neurology 2019 05;92(22):e2614-e2617

From the Department of Neurology, NYU School of Medicine, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000007582DOI Listing
May 2019

Xpert MTB/RIF Ultra: Optimal procedures for the detection of in cerebrospinal fluid.

J Clin Tuberc Other Mycobact Dis 2019 Feb 4;14:16-18. Epub 2019 Jan 4.

Department of Medicine, Makerere University, Kampala, Uganda.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jctube.2019.01.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830139PMC
February 2019

Clinical Reasoning: A 41-year-old man with thunderclap headache.

Neurology 2018 07;91(1):e87-e91

From the Departments of Neurology (S. Grossman, A.R., J.C., L.G., S. Galetta) and Psychiatry (L.G.), New York University, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000005738DOI Listing
July 2018

The salience network causally influences default mode network activity during moral reasoning.

Brain 2013 Jun 9;136(Pt 6):1929-41. Epub 2013 Apr 9.

Memory and Ageing Centre, Department of Neurology, University of California, San Francisco, CA 94158, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/brain/awt066DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673466PMC
June 2013

In vitro and in vivo metabolism and pharmacokinetics of BMS-562086, a potent and orally bioavailable corticotropin-releasing factor-1 receptor antagonist.

Drug Metab Dispos 2012 Jun 1;40(6):1093-103. Epub 2012 Mar 1.

Department of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., P.O. Box 4000, Princeton, NJ 08543, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/dmd.111.043596DOI Listing
June 2012

Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitor.

Eur J Drug Metab Pharmacokinet 2011 Sep 2;36(3):129-39. Epub 2011 Apr 2.

Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Company, Princeton, NJ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13318-011-0037-xDOI Listing
September 2011

Tissue distribution and elimination of [14C]apixaban in rats.

Drug Metab Dispos 2011 Feb 11;39(2):256-64. Epub 2010 Nov 11.

Pharmaceutical Candidate Optimization , Bristol-Myers Squibb, P.O. Box 4000, Princeton, NJ 08543, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/dmd.110.036442DOI Listing
February 2011

In vitro assessment of metabolic drug-drug interaction potential of apixaban through cytochrome P450 phenotyping, inhibition, and induction studies.

Drug Metab Dispos 2010 Mar 25;38(3):448-58. Epub 2009 Nov 25.

Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, Princeton, New Jersey 08543, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/dmd.109.029694DOI Listing
March 2010

'The quicksand of forgetfulness': semantic dementia in One hundred years of solitude.

Brain 2009 Sep 15;132(Pt 9):2609-16. Epub 2009 May 15.

Memory and Aging Center, UCSF Department of Neurology, San Francisco, CA 94143-1207, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/brain/awp100DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139943PMC
September 2009

Comparative metabolism of 14C-labeled apixaban in mice, rats, rabbits, dogs, and humans.

Drug Metab Dispos 2009 Aug 6;37(8):1738-48. Epub 2009 May 6.

Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, Princeton, NJ 08543-4000, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/dmd.108.025981DOI Listing
August 2009

Simplifying the setup for vacuum-outlet GC: using a restriction inside the injection port.

J Sep Sci 2009 Jun;32(11):1849-57

Restek Corporation, Middelburg, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jssc.200900009DOI Listing
June 2009

Increased hepatobiliary clearance of unconjugated thyroxine determines DMP 904-induced alterations in thyroid hormone homeostasis in rats.

Toxicol Sci 2005 Apr 26;84(2):232-42. Epub 2005 Jan 26.

Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, Connecticut 06492-7660, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/toxsci/kfi094DOI Listing
April 2005

The chimpanzee (Pan troglodytes) as a pharmacokinetic model for selection of drug candidates: model characterization and application.

Drug Metab Dispos 2004 Dec 27;32(12):1359-69. Epub 2004 Aug 27.

Discovery Metabolism and Pharmacokinetics, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, Connecticut 06492-7660, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/dmd.104.000943DOI Listing
December 2004

N-phenylphenylglycines as novel corticotropin releasing factor receptor antagonists.

J Med Chem 2004 May;47(10):2426-9

Bristol-Myers Squibb Pharma Research Laboratories, 4570 Executive Drive, Suite 400, San Diego, California 92121, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/jm049974iDOI Listing
May 2004

Imidazo[4,5-c]pyridines as corticotropin releasing factor receptor ligands.

Bioorg Med Chem Lett 2003 Jan;13(1):129-31

Discovery Chemistry-Wilmington, Bristol-Myers Squibb Company, Experimental Station, DE 19880, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0960-894x(02)00834-xDOI Listing
January 2003

Drug metabolites in safety testing.

Toxicol Appl Pharmacol 2002 Aug;182(3):188-96

Merck Research Laboratories, West Point, Pennsylvania 19486, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1006/taap.2002.9440DOI Listing
August 2002